Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-17-025617

Pres. & Chief Executive Offic sold 720 shares at $2.41 ($1,735)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BRISTOW MICHAEL R Pres. & Chief Executive Offic 2017-04-04 Sale −720 $2.41 $1,735 41,155 D
Open-market sales · 720 sh · avg $2.41 · $1,735
Loading xslF345X03/doc4.xml…